Sector consensus Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.980 USD | +1.71% |
|
+1.02% | +8.36% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.93 | +334% | 15 | ||||||
| 663.52 | +34.51% | 23 | ||||||
| 187.29 | +18.71% | 21 | ||||||
| 225.63 | +32.2% | 19 | ||||||
| 412.35 | +56.98% | 27 | ||||||
| 253,509.92 | +45.19% | 24 | ||||||
| 442.83 | -3.12% | 12 | ||||||
| 70.89 | +13.34% | 14 | ||||||
| 104.57 | +40.71% | 23 | ||||||
| 153.25 | +6.97% | 16 | ||||||
| 66.53 | +36.37% | 15 | ||||||
| 214.6 | +17.69% | 15 | ||||||
| 61.31 | +11.47% | 13 | ||||||
| 108.4 | +22.76% | 6 | ||||||
| 43.82 | +19.79% | 14 | ||||||
| 46.12 | +3.63% | 16 | ||||||
| 119.19 | +32.58% | 21 | ||||||
| Average | 15,084.89 | +42.58% | 17 | ||||||
| Weighted average by Cap. | 24,404.99 | +29.50% | 20 |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
